NABTT 2105: A phase I dose-escalation trial of GliaSite brachytherapy with conventional radiation therapy for newly diagnosed glioblastoma multiforme.

被引:0
|
作者
Stieber, VW
Tatter, S
Mikkelsen, T
Barnett, G
Judy, K
Ye, X
Desideri, S
机构
[1] Wake Forest Univ, NABTT CNS Consortium, Winston Salem, NC 27109 USA
[2] Henry Ford Hosp, Detroit, MI 48202 USA
[3] Cleveland Clin, Cleveland, OH 44106 USA
[4] Univ Penn, Philadelphia, PA 19104 USA
[5] Johns Hopkins Univ, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:131S / 131S
页数:1
相关论文
共 50 条
  • [1] A phase I dose-escalation trial of GliaSite brachytherapy for recurrent glioblastoma multiforme.
    Mikkelsen, T
    Kleinberg, L
    Judy, K
    Ye, X
    Stieber, V
    Desideri, S
    Fisher, JD
    Grossman, SA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 126S - 126S
  • [2] Concurrent Olaparib and Radiation Therapy in Older Patients With Newly Diagnosed Glioblastoma: The Phase 1 Dose-Escalation PARADIGM Trial
    Derby, Sarah
    Jackson, Mark R.
    Williams, Karin
    Stobo, Jamie
    Kelly, Caroline
    Sweeting, Lorna
    Shad, Shumaila
    Herbert, Christopher
    Short, Susan C.
    Williamson, Aoife
    James, Allan
    Nowicki, Stefan
    Bulbeck, Helen
    Chalmers, Anthony J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : 1371 - 1378
  • [3] Phase II trial of erlotinib with temozolomide and concurrent radiation therapy in patients with newly-diagnosed glioblastoma multiforme.
    Brewer, CJ
    Suh, JH
    Stevens, GHJ
    Barnett, GH
    Toms, S
    Vogelbaum, MA
    Weil, R
    Peereboom, DM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 130S - 130S
  • [4] Phase I/II dose-escalation study of VB-111, an antiangiogenic gene therapy, in patients with recurrent glioblastoma multiforme.
    Brenner, Andrew Jacob
    Cohen, Yael
    Vredenburgh, James J.
    Peters, Katherine B.
    Breitbart, Eyal
    Bangio, Livnat
    Sher, Naamit
    Harats, Dror
    Wen, Patrick Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Phase I trial of dimethyl fumarate, temozolomide, and radiation therapy in glioblastoma multiforme.
    Shafer, Danielle A.
    Chen, Zhi-jian
    Harris, Timothy
    Tombes, Mary Beth
    Shrader, Ellen
    Strickler, Kathryn
    Ryan, Alison A.
    Dent, Paul
    Malkin, Mark Gordon
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma (INTRAGO): An Open-Label, Dose-Escalation Phase I/II Trial
    Giordano, Frank A.
    Brehmer, Stefanie
    Muerle, Bettina
    Welzel, Grit
    Sperk, Elena
    Keller, Anke
    Abo-Madyan, Yasser
    Scherzinger, Elisabeth
    Clausen, Sven
    Schneider, Frank
    Herskind, Carsten
    Glas, Martin
    Seiz-Rosenhagen, Marcel
    Groden, Christoph
    Haenggi, Daniel
    Schmiedek, Peter
    Emami, Bahman
    Souhami, Luis
    Petrecca, Kevin
    Wenz, Frederik
    [J]. NEUROSURGERY, 2019, 84 (01) : 41 - 49
  • [7] PHASE I TRIAL OF DOSE PER FRACTION ESCALATION OF HYPOFRACTIONATED IMRT WITH TEMOZOLOMIDE CHEMOTHERAPY FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Chen, Changhu
    Damek, Denise M.
    Waziri, Allen E.
    Gaspar, Laurie Elizabeth
    Lillehei, Kevin O.
    Kane, Madeleine
    Robischon, Monica
    Kavanagh, Brian
    [J]. NEURO-ONCOLOGY, 2009, 11 (05) : 662 - 662
  • [8] NTCP Modeling of Dose-escalation Hypofractionated Stereotactic Radiation Therapy (HFSRT) for Patients With Subtotally Resected (STR) Newly Diagnosed Glioblastoma Multiforme (GBM)
    Yondorf, M.
    Wang, S.
    Zhou, L.
    Chang, J.
    Desai, P.
    Parashar, B.
    Nori, D.
    Chao, K.
    Wernicke, A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S272 - S272
  • [9] PHASE I TRIAL OF DIMETHYL FUMARATE, TEMOZOLOMIDE AND RADIATION THERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME: A PRELIMINARY NEUROCOGNITIVE PERSPECTIVE
    Loughan, Ashlee
    Shafer, Danielle
    Lanoye, Autumn
    Braun, Sarah
    Dent, Paul
    Malkin, Mark
    [J]. NEURO-ONCOLOGY, 2017, 19 : 141 - 142
  • [10] NABTT 0306: A randomized phase II trial of EMD 121974 in conjunction with concomitant and adjuvant temozolomide with radiation therapy in patients with newly diagnosed glioblastoma multiforme (GBM)
    Nabors, L. B.
    Mikkelsen, T.
    Batchelor, T.
    Lesser, G.
    Rosenfeld, M.
    Ye, X.
    Piantadosi, S.
    Olson, J.
    Brem, S.
    Grossman, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)